These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25039167)

  • 1. [Progress of berberine for treatment of type 2 diabetes].
    Deng XW; Xie N
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1374-8. PubMed ID: 25039167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
    Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
    Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine.
    Lao-ong T; Chatuphonprasert W; Nemoto N; Jarukamjorn K
    Pharm Biol; 2012 Aug; 50(8):1007-12. PubMed ID: 22775417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-diabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility.
    Chen G; Lu F; Xu L; Dong H; Yi P; Wang F; Huang Z; Zou X
    Phytomedicine; 2013 Jul; 20(10):780-6. PubMed ID: 23582408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.
    Cicero AF; Tartagni E
    Hosp Pract (1995); 2012 Apr; 40(2):56-63. PubMed ID: 22615079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel berberine-metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats.
    Jia D; Li ZW; Zhou X; Gao Y; Feng Y; Ma M; Wu Z; Li W
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):533-544. PubMed ID: 30883863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms.
    Ni WJ; Ding HH; Tang LQ
    Eur J Pharmacol; 2015 Aug; 760():103-12. PubMed ID: 25912800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine and Its Role in Chronic Disease.
    Cicero AF; Baggioni A
    Adv Exp Med Biol; 2016; 928():27-45. PubMed ID: 27671811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms].
    Zhang Q; Li Y; Chen L
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(9):1660-5. PubMed ID: 26323125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional chinese medicine in treatment of metabolic syndrome.
    Yin J; Zhang H; Ye J
    Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):99-111. PubMed ID: 18537696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats.
    Shan CY; Yang JH; Kong Y; Wang XY; Zheng MY; Xu YG; Wang Y; Ren HZ; Chang BC; Chen LM
    J Endocrinol; 2013 Sep; 218(3):255-62. PubMed ID: 23757509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.
    Tang J; Feng Y; Tsao S; Wang N; Curtain R; Wang Y
    J Ethnopharmacol; 2009 Oct; 126(1):5-17. PubMed ID: 19686830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
    Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y
    Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies.
    Chang W; Chen L; Hatch GM
    Biochem Cell Biol; 2015 Oct; 93(5):479-86. PubMed ID: 25607236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
    Kim ED; Kim E; Lee JH; Hyun CK
    Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats.
    Tang LQ; Wei W; Chen LM; Liu S
    J Ethnopharmacol; 2006 Nov; 108(1):109-15. PubMed ID: 16759828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdependence of hepatic lipid and glucose metabolism: novel pharmacological targets for diabetes.
    Lind P
    Curr Opin Investig Drugs; 2004 Apr; 5(4):395-401. PubMed ID: 15134280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell.
    Shen N; Huan Y; Shen ZF
    Eur J Pharmacol; 2012 Nov; 694(1-3):120-6. PubMed ID: 22955013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.